Lizzy Lawrence is an FDA Reporter at STAT. She leads the coverage of pharmaceuticals and healthcare systems, drawing on her extensive background in medical devices, public health, and technology. Lizzy's work has been featured in Protocol, The Middlebury Campus, STAT News, and RamaOnHealthcare.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Lizzy Lawrence's articles mainly focus on healthcare, medical devices, FDA regulations, and technological innovations in the healthcare industry. Her coverage attributes indicate that she often relies on government announcements, legal policy regulation updates, and cited data to develop her stories.
Given this information, if you are reaching out to Lizzy Lawrence with a pitch or as a source for an article related to her coverage topics such as healthcare innovation or recent regulatory changes in the medical device industry would likely be well received by her. She may also be interested in interviews with experts who can provide insights into emerging trends within the healthcare technology sector.
It is important to note that while there isn't a specific geographic focus mentioned for Lizzy's coverage area, it would still be beneficial to ensure any pitches or sources align with relevant international developments in the field of healthcare and medical technology.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Chelsea Cirruzzo, Lizzy Lawrence, Anil Oza
Thousands of HHS staff who shape policy have had their employment status changed to a designation that makes it easier for them to be fired
The FDA said it will allow Colorado to import certain prescription drugs from Canada in an effort to bring prices down for residents.
By: Lizzy Lawrence, Ed Silverman
Florida became first state to receive approval, in 2024, but has yet to start importing drugs
Health officials tout effort to develop drugs more quickly, compete with China
By: Lizzy Lawrence
Sources point to a single instance in which experimental therapy retatrutide was provided for ‘compassionate use'
By: Lizzy Lawrence
Hassan and Lieu question whether 79-year-old patient was Trump WASHINGTON — Democratic lawmakers have questions about the 79-year-old patient
By: Lizzy Lawrence, Sarah Todd
New panelists could benefit from rule changes, raising ethics concerns
The departure of Vijay Kumar follows a broader leadership shakeup at the FDA.
FDA's crackdown on online ketamine retailers, unprecedented health care premium hikes, and more health news from Morning Rounds
By: Lizzy Lawrence, Chelsea Cirruzzo
In a private meeting, HHS officials met with mental health professionals to work on guidance for stopping SSRIs.
